Literature DB >> 17537878

Continuing alendronate for an additional 5 years maintained bone mineral density in postmenopausal women.

Cory Baillie1.   

Abstract

Entities:  

Year:  2007        PMID： 17537878     DOI： 10.1136/ebm.12.3.70

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  2 in total

1.  Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women.

Authors:  Monika A Izano; Romain Neugebauer; Bruce Ettinger; Rita Hui; Malini Chandra; Annette L Adams; Fang Niu; Susan M Ott; Joan C Lo
Journal:  J Manag Care Spec Pharm       Date:  2019-06

2.  Determinants of Oral Bisphosphonate Use Beyond 5 Years.

Authors:  Monika A Izano; Joan C Lo; Bruce Ettinger; Susan M Ott; Bonnie H Li; Fang Niu; Rita L Hui; Romain Neugebauer; Annette L Adams
Journal:  J Manag Care Spec Pharm       Date:  2020-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.